Dittya Sutar

2 weeks ago · 2 min. reading time · visibility 0 ·

chat Contact the author

thumb_up Relevant message Comment

Hematologic Malignancies Testing Market Industry Analysis, Size, Share and Forecast 2021 – 2027

Based on the in-depth analysis the research also brings to light major facts pertaining to the vital aspects such as market share, size, and growth rate. Deep dive into other aspects including the investment feasibility, demand and supply, import and export status, supply chain management and growth prospects narrates a lot about what the business environment will be like for the forecast period,2020 - 2027. All the vital statistics in the report are explained with the help of resources such as tables, charts, and info graphics.

The global Hematologic Malignancies Testing Market is forecasted to be worth USD 5.45 Billion by 2027, according to a current analysis by Emergen Research.  The rapid growth of the global market for Hematologic Malignancies Testing can be attributed to the rising prevalence of Leukemia and Multiple myeloma. 10% of all hematologic cancers are due to multiple myeloma. It is estimated that about 12,830 deaths from multiple myeloma (7,190 in men and 5,640 in women) will happen in 2020.

Besides, increasing awareness among patients and healthcare professionals about the initial diagnosis of Hematologic Malignancies is anticipated to stimulate growth over the forecasted timeframe. Furthermore, the rising emphasis on personalized medicine is also expected to drive the market growth of global Hematologic Malignancies Testing. This procedure can be used in a very particular way to identify and diagnose disorders, classifying those through hereditary variance instead of by symptoms. This encourages more precise and efficient therapies, strengthening the prognosis of patients.

YA7qY.png

 Read more@ 

 

Key Highlights From The Report

In March 2020, Sysmex Corporation received japan marketing clearance for BGI Genomics Coronavirus kit distribution. This initiative will strengthen its position in Japan.

During the forecast timeline, the Next-generation sequencing segment will hold the largest market with a CAGR of 14.8%. In next-generation sequencing, the steadily developing cohort of technologies allowing the detection of gene variations present in Rna and DNA. In the case of hematologic malignancies, such differences provide diagnostic relevance.

It is expected that the Leukemia segment will hold the largest market throughout the forecasted period. The demand for early diagnosis and growing the cases of leukemia are expected to drive the growth of this segment.

The region of North America accounts for the largest market in the forecast timeline. The presence of the key players, and the existing advanced healthcare facilities, are the forces responsible for growth.

Key participants include ArcherDx, Inc., Bio-Rad Laboratories, Inc., Sysmex Corporation, Invitae Corporation, NeoGenomics Laboratories, Inc., Abbott Laboratories, Cancer Genetics Inc., Adaptive Biotechnologies Corporation, Asuragen, Inc., and Invivoscribe, Inc. among others.

 

Request For Free Sample@ 

 

Product Outlook (Revenue, USD Billion; 2017-2027)

Services

Kits

Technology Outlook (Revenue, USD Billion; 2017-2027)

Polymerase Chain Reaction

Immunohistochemistry

Next-generation sequencing

Fluorescence in situ hybridization

Disease Outlook (Revenue, USD Billion; 2017-2027)

Multiple myeloma

Myelodysplastic syndrome

Leukemia

Myeloproliferative neoplasms

Lymphoma

End-Use Outlook (Revenue, USD Billion; 2017-2027)

Research Institutions

Hospitals

Specialty Clinics

Laboratories

Regional Outlook (Revenue, USD Billion; 2017-2027)

North America

Europe

Asia Pacific

Latin America

MEA

 

Table of Content

Chapter 1. Methodology & Sources

    1.1. Hematologic Malignancies Testing Market Definition

    1.2. Hematologic Malignancies Testing Market Research Scope

    1.3. Hematologic Malignancies Testing Market Methodology

    1.4. Hematologic Malignancies Testing Market Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

   1.5. Hematologic Malignancies Testing Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Hematologic Malignancies Testing Market Segmentation & Impact Analysis

 

Continued…

Find similar reports by Emergen Research

Medical Supplies Market  By Type, By Application (Urology, Wound Care, Radiology, Respiratory, Infection Control, Cardiology, IVD, Other Applications), By End User (Hospitals, Clinics, Others), and By Region, Forecasts to 2027

Cloud Billing Market  By Component (Solution Services), By Billing Type, By Deployment Type (Private, Public), By Service Model (IaaS, PaaS, SaaS), By Organization Size (Large Enterprises, Small and Medium-Sized Enterprise), By Vertical, and By Region, Forecasts to 2027

Nanopharmaceutical Drugs Market  By Type, By Application, By Distribution Channel, Forecasts to 2027

Clinical Perinatal Software Market  By Product Type, By Deployment Mode, By Application, By End-User, Forecasts to 2027

About Emergen Research

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us: Eric Lee

Web: 

E-mail: sales@emergenresearch.com

 

thumb_up Relevant message Comment
Comments